Treatment With Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic β-Cells From Streptozotocin-Induced Diabetes in vitro and in vivo

by Rashmi Rajappa, Dornadula Sireesh, Magesh B. Salai, Kunka M. Ramkumar, Suryanarayanan Sarvajayakesavulu, SubbaRao V. Madhunapantula
Published 2019-01-01